Ascher Benjamin, Bayerl Christiane, Kestemont Philippe, Rzany Berthold, Edwartz Carolina, Podda Maurizio
*Clinique de Chirurgie Esthétique Iéna, Paris, France; †Department of Dermatology and Allergology, HELIOS HSK Wiesbaden, Lehrkrankenhaus der Universität Mainz, Wiesbaden, Germany; ‡Clinique Esthétique St. George, Nice, France; §RZANY & HUND, Privatpraxis, Berlin, Germany; ‖Galderma A&C, Uppsala, Sweden; ¶Department of Dermatology, Klinikum Darmstadt, Darmstadt, Germany.
Dermatol Surg. 2017 Mar;43(3):389-395. doi: 10.1097/DSS.0000000000001031.
Hyaluronic acid (HA) filler injection is an increasingly popular aesthetic procedure.
To compare the effectiveness and safety of two HA fillers (HAED and HAPER) for the treatment of severe nasolabial folds (NLFs).
This was an evaluator-blinded and subject-blinded split-face study. At baseline, HAED or HAPER was randomly assigned to the left or right NLF. The follow-up period was 12 months. Effectiveness was assessed using the wrinkle severity rating scale (WSRS) and subject preference. Safety was assessed by adverse events and local tolerability symptoms recorded by subjects during 3 weeks after the treatment.
At 6 months, HAED was noninferior to HAPER (assessed by mean change from baseline in WSRS score). There was a significant difference in mean WSRS score change from baseline in favor of HAED at 3 to 12 months, and a majority of subjects preferred HAED over HAPER at 12 months. However, the overall responder rate was similar between products, and it remained high throughout the study. At 12 months, approximately 80% of subjects were still responders. Both products were well tolerated and associated with a few treatment-related adverse events.
To conclude, HAED was at least as effective and well tolerated for the treatment of severe NLFs as HAPER.
透明质酸(HA)填充剂注射是一种越来越受欢迎的美容手术。
比较两种HA填充剂(HAED和HAPER)治疗重度鼻唇沟(NLFs)的有效性和安全性。
这是一项评估者盲法和受试者盲法的半脸研究。在基线时,将HAED或HAPER随机分配到左侧或右侧鼻唇沟。随访期为12个月。使用皱纹严重程度评分量表(WSRS)和受试者偏好评估有效性。通过治疗后3周内受试者记录的不良事件和局部耐受性症状评估安全性。
在6个月时,HAED不劣于HAPER(通过WSRS评分从基线的平均变化评估)。在3至12个月时,从基线的平均WSRS评分变化存在显著差异,有利于HAED,并且在12个月时,大多数受试者更喜欢HAED而不是HAPER。然而,两种产品的总体应答率相似,并且在整个研究过程中保持较高。在12个月时,约80%的受试者仍是应答者。两种产品耐受性良好,且与一些治疗相关的不良事件有关。
总之,HAED在治疗重度鼻唇沟方面至少与HAPER一样有效且耐受性良好。